. .
Français
France
Livres similaires
Autres livres qui pourraient ressembler au livre recherché:
Outils de recherche
s'inscrire

Connectez-vous avec Facebook:

S'inscrire
Mot de passe oublié?


Historique de recherche
Liste pense-bête
Liens vers eurolivre.fr

Partager ce livre sur…
Livre conseillé
Actualités
Conseils d'eurolivre.fr
Publicité
FILTRE
- 0 Résultats
prix le plus bas: 46,09 €, prix le plus élevé: 92,96 €, prix moyen: 72,65 €
Pharming - E. Rehbinder#M. Engelhard#K. Hagen#R. B. Jørgensen#R. Pardo-Avellaneda
Livre non disponible
(*)
E. Rehbinder#M. Engelhard#K. Hagen#R. B. Jørgensen#R. Pardo-Avellaneda:

Pharming - nouveau livre

2008, ISBN: 9783540857921

ID: 226160568

Recent scientific advances have made it possible to produce biopharmaceuticals in genetically modified plants and animals, such as maize, tobacco, goats, and chickens. This new branch of biotechnology is termed pharming, composed of the terms pharmaceuticals and farming. Pharming constitutes an overlap of red and green biotechnology. It offers the prospect of a quicker, cheaper, and more flexible production of biopharmaceuticals compared with current production processes. This is a promising perspective in light of the rapidly growing market of biopharmaceuticals, although the economic competitiveness of pharming remains to be proven. Besides possible benefits for producers, patients and health care systems, pharming also raises a number of complex ecological, social, moral and legal questions that have as yet not been thoroughly discussed. The present book contains the findings of an interdisciplinary research project that has addressed a large range of questions associated with pharming: An analysis of the state-of-the-art of plant pharming and animal pharming technologies is followed by an assessment of environmental risks related to pharming and welfare risks for pharming animals. Public views and attitudes to pharming are investigated on the basis of a comprehensive survey in 15 countries. Moreover, ethical and legal questions, posed by present and foreseeable future practices of pharming, are analysed. The concluding chapter presents the authors main findings and recommendations, addressed to science, industry, politics and general public interested in the chances and risks of this upcoming field of biotechnology. A recently established technique termed pharming uses genetically modified plants and animals for the production of biopharmaceuticals. The present interdisciplinary study comprises an extended overview of the state of the art of pharming, as well as in depth analyses of the environmental risks and other ethical and legal issues of pharming. Public attitudes to pharming are investigated on the basis of an original survey in 15 countries worldwide. The study concludes with specific recommendations addressed towards science, industry and politics. This book covers issues in Pharming, a new branch of biotechnology where plants or animals are genetically engineered to produce pharmaceutical proteins. Coverage includes recommendations for the further development and regulation of pharming. Bücher > Fremdsprachige Bücher > Englische Bücher gebundene Ausgabe 17.10.2008 Buch (fremdspr.), Springer, .200

Nouveaux livres Buch.ch
No. 15990919 Frais d'envoizzgl. Versandkosten, Livraison non-comprise
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.
Pharming - E. Rehbinder#M. Engelhard#K. Hagen#R. B. Jørgensen#R. Pardo-Avellaneda
Livre non disponible
(*)

E. Rehbinder#M. Engelhard#K. Hagen#R. B. Jørgensen#R. Pardo-Avellaneda:

Pharming - nouveau livre

ISBN: 9783540857921

ID: 187708722

Recent scientific advances have made it possible to produce biopharmaceuticals in genetically modified plants and animals, such as maize, tobacco, goats, and chickens. This new branch of biotechnology is termed pharming, composed of the terms pharmaceuticals and farming. Pharming constitutes an overlap of red and green biotechnology. It offers the prospect of a quicker, cheaper, and more flexible production of biopharmaceuticals compared with current production processes. This is a promising perspective in light of the rapidly growing market of biopharmaceuticals, although the economic competitiveness of pharming remains to be proven. Besides possible benefits for producers, patients and health care systems, pharming also raises a number of complex ecological, social, moral and legal questions that have as yet not been thoroughly discussed. The present book contains the findings of an interdisciplinary research project that has addressed a large range of questions associated with pharming: An analysis of the state-of-the-art of plant pharming and animal pharming technologies is followed by an assessment of environmental risks related to pharming and welfare risks for pharming animals. Public views and attitudes to pharming are investigated on the basis of a comprehensive survey in 15 countries. Moreover, ethical and legal questions, posed by present and foreseeable future practices of pharming, are analysed. The concluding chapter presents the authors main findings and recommendations, addressed to science, industry, politics and general public interested in the chances and risks of this upcoming field of biotechnology. A recently established technique termed pharming uses genetically modified plants and animals for the production of biopharmaceuticals. The present interdisciplinary study comprises an extended overview of the state of the art of pharming, as well as in depth analyses of the environmental risks and other ethical and legal issues of pharming. Public attitudes to pharming are investigated on the basis of an original survey in 15 countries worldwide. The study concludes with specific recommendations addressed towards science, industry and politics. This book covers issues in Pharming, a new branch of biotechnology where plants or animals are genetically engineered to produce pharmaceutical proteins. Coverage includes recommendations for the further development and regulation of pharming. Buch (fremdspr.) Bücher>Fremdsprachige Bücher>Englische Bücher, Springer

Nouveaux livres Thalia.de
No. 15990919 Frais d'envoi, Sofort lieferbar, DE (EUR 0.00)
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.
Pharming - F. Thiele#A. Schnieke#R. Pardo-Avellaneda#R. B. Jørgensen#K. Hagen
Livre non disponible
(*)
F. Thiele#A. Schnieke#R. Pardo-Avellaneda#R. B. Jørgensen#K. Hagen:
Pharming - nouveau livre

ISBN: 9783540857921

ID: 187708722

Recent scientific advances have made it possible to produce biopharmaceuticals in genetically modified plants and animals, such as maize, tobacco, goats, and chickens. This new branch of biotechnology is termed pharming, composed of the terms pharmaceuticals and farming. Pharming constitutes an overlap of red and green biotechnology. It offers the prospect of a quicker, cheaper, and more flexible production of biopharmaceuticals compared with current production processes. This is a promising perspective in light of the rapidly growing market of biopharmaceuticals, although the economic competitiveness of pharming remains to be proven. Besides possible benefits for producers, patients and health care systems, pharming also raises a number of complex ecological, social, moral and legal questions that have as yet not been thoroughly discussed. The present book contains the findings of an interdisciplinary research project that has addressed a large range of questions associated with pharming: An analysis of the state-of-the-art of plant pharming and animal pharming technologies is followed by an assessment of environmental risks related to pharming and welfare risks for pharming animals. Public views and attitudes to pharming are investigated on the basis of a comprehensive survey in 15 countries. Moreover, ethical and legal questions, posed by present and foreseeable future practices of pharming, are analysed. The concluding chapter presents the authors main findings and recommendations, addressed to science, industry, politics and general public interested in the chances and risks of this upcoming field of biotechnology. A recently established technique termed pharming uses genetically modified plants and animals for the production of biopharmaceuticals. The present interdisciplinary study comprises an extended overview of the state of the art of pharming, as well as in depth analyses of the environmental risks and other ethical and legal issues of pharming. Public attitudes to pharming are investigated on the basis of an original survey in 15 countries worldwide. The study concludes with specific recommendations addressed towards science, industry and politics. This book covers issues in Pharming, a new branch of biotechnology where plants or animals are genetically engineered to produce pharmaceutical proteins. Coverage includes recommendations for the further development and regulation of pharming. Buch (fremdspr.) Bücher>Fremdsprachige Bücher>Englische Bücher, Springer

Nouveaux livres Thalia.de
No. 15990919 Frais d'envoi, Sofort lieferbar, DE (EUR 0.00)
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.
Pharming: Promises and risks ofbBiopharmaceuticals derived from genetically modified plants and animals (Ethics of Science and Technology Assessment)
Livre non disponible
(*)
Pharming: Promises and risks ofbBiopharmaceuticals derived from genetically modified plants and animals (Ethics of Science and Technology Assessment) - livre d'occasion

ISBN: 9783540857921

ID: a94c31765a94a55c965e56f4179c2dad

A recently established technique termed pharming uses genetically modified plants and animals for the production of biopharmaceuticals. The present interdisciplinary study comprises an extended overview of the state of the art of pharming, as well as in depth analyses of the environmental risks and other ethical and legal issues of pharming. Public attitudes to pharming are investigated on the basis of an original survey in 15 countries worldwide. The study concludes with specific recommendations addressed A recently established technique termed pharming uses genetically modified plants and animals for the production of biopharmaceuticals. The present interdisciplinary study comprises an extended overview of the state of the art of pharming, as well as in depth analyses of the environmental risks and other ethical and legal issues of pharming. Public attitudes to pharming are investigated on the basis of an original survey in 15 countries worldwide. The study concludes with specific recommendations addressed towards science, industry and politics., [PU: Springer, Berlin/Heidelberg]

livre d'occasion Medimops.de
Nr. M03540857923 Frais d'envoi, 3, DE. (EUR 0.00)
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.
Pharming Promises and risks of biopharmaceuticals derived from genetically modified plants and animals - Rehbinder, E.; Engelhard, M.; Hagen, K.; Jørgensen, R. B.; Pardo-Avellaneda, R.; Schnieke, A.; Thiele, F.
Livre non disponible
(*)
Rehbinder, E.; Engelhard, M.; Hagen, K.; Jørgensen, R. B.; Pardo-Avellaneda, R.; Schnieke, A.; Thiele, F.:
Pharming Promises and risks of biopharmaceuticals derived from genetically modified plants and animals - edition reliée, livre de poche

2008, ISBN: 3540857923

ID: A6102438

Gebundene Ausgabe Biochemie, Chemie / Biochemie, Biomedizin, Medizin / Biomedizin, Ethik, Ethos, Philosophie / Ethik, Arznei / Arzneimittellehre, Pharmakologie, Toxikologie, mit Schutzumschlag neu, [PU:Springer-Verlag GmbH]

Nouveaux livres Achtung-Buecher.de
REDIVIVUS Buchhandlung Hanausch Reinhard, 93053 Regensburg
Frais d'envoiVersandkostenfrei innerhalb der BRD (EUR 0.00)
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.

< Retour aux résultats de recherche...
Détails sur le livre
Pharming
Auteur:

Rehbinder, E.; Engelhard, M.; Hagen, K.; Jørgensen, R. B.; Pardo-Avellaneda, R.; Schnieke, A.; Thiele, F.

Titre:

Pharming

ISBN:

3540857923

A recently established technique termed pharming uses genetically modified plants and animals for the production of biopharmaceuticals. The present interdisciplinary study comprises an extended overview of the state of the art of pharming, as well as in depth analyses of the environmental risks and other ethical and legal issues of pharming. Public attitudes to pharming are investigated on the basis of an original survey in 15 countries worldwide. The study concludes with specific recommendations addressed towards science, industry and politics.

Informations détaillées sur le livre - Pharming


EAN (ISBN-13): 9783540857921
ISBN (ISBN-10): 3540857923
Version reliée
Livre de poche
Date de parution: 2008
Editeur: Springer-Verlag GmbH
334 Pages
Poids: 0,652 kg
Langue: eng/Englisch

Livre dans la base de données depuis 30.11.2008 16:53:09
Livre trouvé récemment le 05.03.2017 09:00:12
ISBN/EAN: 3540857923

ISBN - Autres types d'écriture:
3-540-85792-3, 978-3-540-85792-1

< Retour aux résultats de recherche...
< pour archiver...
Livres en relation